Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study.
Paolo Boscolo-RizzoAndrea D'AlessandroJerry PoleselDaniele BorsettoMargherita TofanelliAlberto DeganelloMichele TomasoniPiero NicolaiPaolo BossiGiacomo SpinatoAnna MenegaldoAndrea CiorbaStefano PelucchiChiara BianchiniDiego CazzadorGiulia RamaciottiValentina LupatoVittorio GiacomarraGabriele MolteniDaniele MarchioniCristoforo FabbrisAntonio OcchiniGiulia BertinoJonathan FusseyGiancarlo TirelliPublished in: BMC cancer (2022)
Different inflammatory blood markers may be useful to identify patients at risk of local, regional, or distant recurrences who may benefit from treatment intensification or intensive surveillance programs.